Literature review on antiobesity medication use for metabolic and bariatric surgery patients from the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee

Affiliations

¹ American Board of Obesity, Denver, Colorado; Department of Surgery, Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts. Electronic address: rvosburg@mah.harvard.edu.
² American Board of Obesity, Denver, Colorado; Department of Surgery, Lewis Katz School of Medicine at Temple University, St. Luke's University and Health Network, Philadelphia, Pennsylvania.
³ Department of Bariatric Surgery, Adventist Medical Center Bolingbrook, Bolingbrook, Illinois.
⁴ Department of Surgery, Morsani College of Medicine, USF Health, Tampa, Florida.
⁵ Department of Surgery, Mount Auburn Hospital, Cambridge, Massachusetts.
⁶ American Board of Obesity, Denver, Colorado; Unitypoint Clinic Weight Loss Specialists, West Des Moines, Iowa; Department of Surgery, University of Iowa, Iowa City, Iowa.
⁷ American Board of Obesity, Denver, Colorado; Vanderbilt Weight Loss, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
⁸ Division of Endocrinology, Diabetes, and Metabolism, Comprehensive Weight Control Center, Weill Cornell Medicine, New York, New York; Weill Center of Metabolic Health, Weill Cornell Medicine, New York, New York.
⁹ Department of Surgery, Houston Methodist Academic Institute, Texas A&M University College of Medicine, Houston, Texas.
¹⁰ American Board of Obesity, Denver, Colorado; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Divisions of Surgery and Endocrinology, Massachusetts General Hospital Weight Center, Boston, Massachusetts.
¹¹ Department of Surgery, Stanford University School of Medicine, Stanford, California.

PMID: 36028428
DOI: 10.1016/j.soard.2022.07.002

Review

Literature review on antiobesity medication use for metabolic and bariatric surgery patients from the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee

R Wesley Vosburg et al. Surg Obes Relat Dis. 2022 Sep.

. 2022 Sep;18(9):1109-1119.

doi: 10.1016/j.soard.2022.07.002. Epub 2022 Jul 14.

Affiliations

¹ American Board of Obesity, Denver, Colorado; Department of Surgery, Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts. Electronic address: rvosburg@mah.harvard.edu.
² American Board of Obesity, Denver, Colorado; Department of Surgery, Lewis Katz School of Medicine at Temple University, St. Luke's University and Health Network, Philadelphia, Pennsylvania.
³ Department of Bariatric Surgery, Adventist Medical Center Bolingbrook, Bolingbrook, Illinois.
⁴ Department of Surgery, Morsani College of Medicine, USF Health, Tampa, Florida.
⁵ Department of Surgery, Mount Auburn Hospital, Cambridge, Massachusetts.
⁶ American Board of Obesity, Denver, Colorado; Unitypoint Clinic Weight Loss Specialists, West Des Moines, Iowa; Department of Surgery, University of Iowa, Iowa City, Iowa.
⁷ American Board of Obesity, Denver, Colorado; Vanderbilt Weight Loss, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
⁸ Division of Endocrinology, Diabetes, and Metabolism, Comprehensive Weight Control Center, Weill Cornell Medicine, New York, New York; Weill Center of Metabolic Health, Weill Cornell Medicine, New York, New York.
⁹ Department of Surgery, Houston Methodist Academic Institute, Texas A&M University College of Medicine, Houston, Texas.
¹⁰ American Board of Obesity, Denver, Colorado; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Divisions of Surgery and Endocrinology, Massachusetts General Hospital Weight Center, Boston, Massachusetts.
¹¹ Department of Surgery, Stanford University School of Medicine, Stanford, California.

PMID: 36028428
DOI: 10.1016/j.soard.2022.07.002

Abstract

The following literature search is in response to inquiries made to the American Society for Metabolic and Bariatric Surgery (ASMBS) regarding antiobesity medication (AOM) use in patients who are having or have already had metabolic and bariatric surgery (MBS). These recommendations are based on current clinical knowledge, expert opinion, and published peer-reviewed scientific evidence available at this time. This paper is not intended to establish a local, regional, or national standard of care. The paper will be revised in the future as additional evidence becomes available.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Literature review on antiobesity medication use for metabolic and bariatric surgery patients from the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee

Affiliations

Literature review on antiobesity medication use for metabolic and bariatric surgery patients from the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee

Authors

Affiliations

Abstract

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical